Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alcon
MedTech
Alcon sees Staar Surgical for $1.5B deal
Alcon plans to pay a premium of 59% over Staar’s average stock price, as the company deals with declining revenues.
Conor Hale
Aug 5, 2025 11:00am
Alcon to buy LumiThera’s light-based therapy for dry AMD
Jul 8, 2025 10:30am
Yet another exec departs CRISPR Tx—Chutes & Ladders
Mar 28, 2025 8:30am
Alcon gains majority stake in Aurion after power struggle
Mar 27, 2025 9:23am
Deerfield suit says Alcon committed 'Valentine's Day massacre'
Feb 24, 2025 5:20pm
Judge rules against investor trying to block Aurion IPO
Jan 28, 2025 2:54pm
